-
Roth Capital Upgrades Spectrum Pharmaceuticals (SPPI) to Buy
-
Notable Analyst Rating Changes 09/12: (ORCL) (LVLT) (MON) Upgraded; (CREE) (SPPI) (NIHD) Downgraded
-
Roth Capital Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral
